Scandion Oncology A/S's total assets for Q4 2024 were kr18.28M, a decrease of -35.61% from the previous quarter. DE:8VY total liabilities were kr10.01M for the fiscal quarter, a 113.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.